QuidelOrtho (QDEL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Executive summary
Annual Meeting scheduled for June 16, 2026, at 8:30 a.m. Pacific Time, to be held virtually via the Internet.
Shareholders are encouraged to review proxy materials and vote by June 15, 2026.
Voting matters and shareholder proposals
Election of ten directors for terms expiring in 2027, with board recommending all nominees.
Advisory vote on the compensation of named executive officers is up for approval.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending January 3, 2027.
Other business may be transacted as properly presented at the meeting or any adjournment.
Board of directors and corporate governance
Ten director nominees listed, including individuals with diverse backgrounds and expertise.
Partial view of Summaries dataset, powered by Quartr API
Latest events from QuidelOrtho
- Shareholders will vote on directors, executive pay, and auditor ratification, with strong governance and ESG focus.QDEL
Proxy filing27 Apr 2026 - FY26 revenue guidance of $2.9B and margin expansion driven by innovation and recurring revenue.QDEL
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - 2025 saw margin expansion and strong Labs growth, with FY26 guidance projecting higher cash flow.QDEL
Q4 202512 Feb 2026 - Q2 revenue fell, but recurring revenue rose 5% as cost savings and impairments shaped results.QDEL
Q2 20242 Feb 2026 - Q1 2024 saw 6% revenue growth ex-COVID-19, with margin focus and global expansion initiatives.QDEL
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Savanna platform and cost optimization drive growth, with Investor Day set for 1H 2025.QDEL
Morgan Stanley’s 22nd Annual Global Healthcare Conference22 Jan 2026 - Savanna platform launch and cost actions position the business for improved growth and profitability.QDEL
Baird 2024 Global Healthcare Conference21 Jan 2026 - Q3 revenue fell 2% but margin rose; $1.7B impairment led to $1.87B net loss YTD.QDEL
Q3 202415 Jan 2026 - 2025 margin expansion, cost savings, and SAVANNA scale-up drive a two- to three-year growth plan.QDEL
Citi's 2024 Global Healthcare Conference11 Jan 2026